Israeli biopharma firm BiomX raises $32 million in private funding

Israeli biopharma firm BiomX said on Wednesday it raised $32 million in a private funding round that will primarily be used to advance the company's drug candidates for the treatment of acne and inflammatory bowel disease (IBD).